Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people
; Rodriguez, Pamela Elizabeth ; Miglietta, Esteban Alberto ; Rall, Pablo ; González López Ledesma, María Mora ; Varese, Augusto ; Pascuale, Carla Antonela ; Ojeda, Diego Sebastian ; Mazzitelli, Bianca ; Sanchez, Lautaro Nicolas ; Ceballos, Ana ; Perez, Eduardo ; Geffner, Jorge Raúl ; Miragaya, Yanina Daniela ; Rossi, Andrés Hugo ; Gamarnik, Andrea Vanesa Otros responsables
Fecha
08/2022
Editorial
Elsevier Science Inc.
Revista
Lancet Infectious Diseases
Título del libro
Nombre del evento
Fecha del evento
Institución organizadora
ISSN
1473-3099
eISSN
ISBN
Idioma
Inglés
Tipo del evento
Clasificación temática
Palabras clave
Resumen
Whole-virion inactivated SARS-CoV-2 vaccines are one of the most widely used vaccines worldwide. However, compared with the mRNA-based and adenovirus-based platforms,1 little information is available about the immune response that is induced by inactivated virus vaccines2 and the convenience of applying heterologous boosters to reach an improved response against variants of concern, including omicron (B.1.1.529). Particularly scarce are data for older people (ie, age >60 years).
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
Cargando...
Archivos
Identificadores
Oviedo Rouco, Santiago; Rodriguez, Pamela Elizabeth; Miglietta, Esteban Alberto; Rall, Pablo; González López Ledesma, María Mora; et al.; Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people; Elsevier Science Inc.; Lancet Infectious Diseases; 22; 8; 8-2022; 1118-1119
Altmétricas